Immunome, Inc. - Common Stock (NQ:IMNM)

18.03 -0.26 (-1.42%)

Delayed Quote Updated: 2:24 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer

October 19, 2023

From Immunome, Inc.

Via Business Wire

Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies

October 03, 2023

From Immunome, Inc.

Via Business Wire

Immunome Reports Second Quarter 2023 Financial Results

August 09, 2023

From Immunome, Inc.

Via Business Wire

Immunome Inc. (NASDAQ: IMNM) Leading the Way in Thursday Trading Based on Percentage Gain

June 29, 2023

Via Investor Brand Network

Why Are Immunome Shares Trading Higher Today ↗

June 29, 2023

Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in

Via Benzinga

Immunome: Q1 Earnings Insights ↗

May 05, 2023

Via Benzinga

Immunome Stock Jumps On Discovery Pact With AbbVie ↗

January 06, 2023

Via Benzinga

Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates ↗

June 29, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P...

Via Benzinga

Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 29, 2023

Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 29, 2023

Via Benzinga

IMNM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Immunome, Inc. Is Fair to Shareholders

June 29, 2023

From Halper Sadeh LLC

Via Business Wire

Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies

June 29, 2023

Via Spotlight Growth

Dow Rises Over 100 Points; US GDP Grows 2% In Q1 ↗

June 29, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 29, 2023

Via Benzinga

Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies

June 29, 2023

From Immunome

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity

May 23, 2023

From Immunome, Inc.

Via Business Wire

Immunome Reports First Quarter 2023 Financial Results

May 05, 2023

From Immunome, Inc.

Via Business Wire

Immunome Reports Fourth Quarter and Full Year 2022 Financial Results

March 16, 2023

From Immunome, Inc.

Via Business Wire

Immunome to Present at 13th Annual World ADC London Conference

March 09, 2023

From Immunome, Inc.

Via Business Wire

Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board

February 08, 2023

From Immunome, Inc.

Via Business Wire

AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal ↗

January 06, 2023

AbbVie is tapping Immunome to help develop new cancer treatments.

Via Investor's Business Daily

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Dow Rises Over 300 Points; US Adds 223,000 Jobs In December ↗

January 06, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.

Via Benzinga

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

January 06, 2023

From Immunome, Inc.

Via Business Wire

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session ↗

November 30, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.

Via Benzinga

Immunome Reports Third Quarter 2022 Financial Results

November 14, 2022

From Immunome, Inc.

Via Business Wire

Immunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

November 09, 2022

From Immunome, Inc.

Via Business Wire

Immunome Announces Publication in Clinical & Translational Immunology Highlighting B Cell Repertoires in Patients with Breast Cancer

August 23, 2022

From Immunome, Inc.

Via Business Wire

Recap: Immunome Q2 Earnings ↗

August 05, 2022

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Immunome beat estimated earnings by...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.